AGEN vs RARE · P/E 1.6, rev $68.3M vs rev $350.0M
Agenus Inc (AGEN) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Agenus Inc (AGEN) is a biotechnology company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported AGEN revenue for 2026-06-30 was $68.3M. Net income was $38.6M. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
AGEN currently screens at market cap $134.5M and trailing P/E 1.6. RARE currently screens at market cap $2.79B.
Not investment advice. Open the AGEN and RARE stock pages for the full models.
Not investment advice.